Condition

Hypoactive Sexual Desire Disorder

ClinicalTrials.gov condition label

Clinical trials4

Recruiting0

Common interventions9

Lead sponsors shown4

Clinical trials

4 shown

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire DisorderNCT07596212 · 2026-09-01

NOT_YET_RECRUITING

Low Sexual Desire and Metabolic SyndromeNCT02430987 · 2014-09-01

COMPLETED

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal WomenNCT00612742 · 2008-01-01

COMPLETED

Effects of Early Abuse on Adult Intimate RelationshipsNCT01803802 · 2005-04-01

COMPLETED

Common interventions

Aromatase InhibitorsDRUG1BupropionDRUG1Evaluation of presence of metabolic syndromeDIAGNOSTIC_TEST1Evaluation of the body mass indexDIAGNOSTIC_TEST1Expressive writingBEHAVIORAL1Female sexual function index questionnaireDIAGNOSTIC_TEST1GnRH agonistDRUG1placebo gelDRUG1testosterone gelDRUG1

Leading sponsors

BioSante Pharmaceuticals1Faculdade de Ciências Médicas da Santa Casa de São Paulo1University of Illinois at Chicago1University of Texas at Austin1

Trial status mix

COMPLETED3

NOT_YET_RECRUITING1

Phase mix

NA2

PHASE11

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.